Skip to main content
Premium Trial:

Request an Annual Quote

Helena Correia

RXi Pharmaceuticals, a spin out of CytRx, has appointed Helena Correia as its vice president of regulatory affairs.
Correia has previously held similar roles at Acambis, Serono, and Boston Scientific, according to RXi.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.